MeSH term
Frequency | Condition_Probility | Female | 4 | 0.0 |
Humans | 31 | 0.0 |
Animals | 26 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Male | 5 | 0.0 |
*Membrane Transport Proteins | 4 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Middle Aged | 3 | 0.0 |
Muscle, Smooth, Vascular/cytology/drug effects/*metabolism | 2 | 7.0 |
NADPH Dehydrogenase/metabolism | 2 | 8.0 |
*NADPH Oxidase | 2 | 5.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Rats | 8 | 0.0 |
Reactive Oxygen Species/metabolism | 8 | 2.0 |
Research Support, Non-U.S. Gov't | 20 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Hydrogen Peroxide/*metabolism | 2 | 5.0 |
Mice | 7 | 0.0 |
RNA, Messenger/metabolism | 7 | 0.0 |
Base Sequence | 6 | 0.0 |
Blotting, Northern | 3 | 0.0 |
COS Cells | 3 | 0.0 |
Cell Line | 9 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Protons | 2 | 2.0 |
Time Factors | 5 | 0.0 |
Transfection | 5 | 0.0 |
NADH, NADPH Oxidoreductases/genetics/*metabolism | 2 | 33.0 |
NADPH Oxidase/genetics/metabolism | 2 | 66.0 |
Phosphoproteins/genetics/metabolism | 2 | 2.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Superoxides/metabolism | 4 | 1.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
NADPH Oxidase/chemistry/*metabolism | 2 | 33.0 |
Protein Binding | 2 | 0.0 |
Cell Division | 2 | 0.0 |
NADH, NADPH Oxidoreductases/*metabolism | 3 | 9.0 |
NADPH Oxidase/*metabolism | 5 | 12.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Superoxides/*metabolism | 7 | 7.0 |
Amino Acid Sequence | 4 | 0.0 |
Caco-2 Cells | 4 | 1.0 |
Cloning, Molecular | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Membrane Glycoproteins/*genetics/metabolism | 2 | 2.0 |
Oxidation-Reduction | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Enzyme Activation | 5 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Gene Expression Regulation, Enzymologic | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
NADPH Oxidase/antagonists & inhibitors/biosynthesis/genetics/*physiology | 2 | 100.0 |
NIH 3T3 Cells | 2 | 0.0 |
Onium Compounds/pharmacology | 2 | 11.0 |
RNA, Small Interfering/genetics | 2 | 1.0 |
NADPH Oxidase/genetics/*metabolism | 4 | 36.0 |
Up-Regulation | 3 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Enzyme Activation/physiology | 2 | 1.0 |
